Meet Acumetis at ISPOR U.S. 2026!
Where to find us
May 17–20, 2026 | Pennsylvania Convention Center, Philadelphia
Visit us at booth #811
Acumetis will be attending ISPOR U.S. 2026 in Philadelphia, the leading global conference for Health Economics and Outcomes Research (HEOR) and market access.
Bringing together more than 4,000 stakeholders across pharma, biotech, payers, HTA bodies, academia, and policy, ISPOR is where evidence, value, and policy converge to shape real-world access decisions. It serves as a critical forum for exploring how clinical and real-world evidence, economic modelling, and evolving policy frameworks influence pricing, reimbursement, and patient access across markets.
Why meet with Acumetis
Acumetis is a global expert commercialization partner purposefully built to help life sciences win in the age of connectivity. With an integrated model spanning the entire asset lifecycle, deep functional and therapeutic-area expertise, and rigorous, outcome-driven thinking, Acumetis reframes complex problems and shapes solutions that are both imaginative and achievable. With more than 350 experts globally and experience across 50+ geographic markets, Acumetis helps clients unlock value, accelerate performance, and deliver better outcomes for patients.
When you reframe what’s possible, new angles emerge, decisions sharpen, and new potential comes to life.
How this comes to life in global value & access
Demonstrate value. Enable access.
Reframing challenges
Bringing creativity, agility, and value by challenging the status quo.
Strategic clarity
Combining deep knowledge of global payer requirements with lived experience of local market nuances.
Critical connection
Connecting evidence strategy, health economics, and market access expertise. Globally connected across the US, EU, and key markets.
Our global value and access experts help create launches that consistently achieve predictable breakthrough success. We lead a fully integrated approach that consistently delivers industry-leading results.
Proven success
→ 250+ payer submissions completed
→ 100+ economic models
→ 60+ HTA submissions
→ 20+ countries covered
Acumetis lands at ISPOR to present on the hot button topics of today: MFN, AI, RWE in rare, and more
At ISPOR, our conversations will center on how organizations are addressing key challenges in practice:
- AI in modelling
- MFN simulation and strategy
- Real world evidence generation in rare disease
- Global market access and the interplay of JCA, MFN, and IRA
How we deliver impact
Achieving global market access requires more than strong clinical data — it requires a value foundation that is strong enough to build on and flexible enough to adapt as markets evolve. Through the integration of FIECON and Decisive under Acumetis, we bring together integrated, multi-capability expertise to define where your asset demonstrates value, build the evidence that proves it, and communicate it in a way that achieves success and drives adoption. Built on 100+ economic models across 20+ countries, our consultants’ partner with you to de-risk the decisions that shape commercialization success for the widest patient population.
Working as an integrated partner, we align HEOR, Medical, and Market Access to connect insights, reduce rework, and move more efficiently from analysis to action—de-risking the decisions that shape commercialization success for the widest patient population.
Who you’ll meet
Steve Fountain: Principal, Global Value and Access
Shloka Shetty: Manager, Global Value and Access
Esther Nzenza: Senior Partner, Global Value and Access Practice Lead
Lawrence Murphy: Business Development Director
Megan Watts: Senior Manager, Global Value and Access
Katerina Papadimitropoulou: Director, HEOR and Statistics
Karl Freemyer: Head of Business Development
Schedule a meeting with the Acumetis team at Booth #811 during ISPOR 2026 to discuss your current priorities across HEOR, market access, and policy strategy.